Trial
NCT00324077
Phase I Study of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phase
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Bristol-Myers Squibb
Collaborators
—
Condition
Myeloid Leukemia, Chronic, Chronic-Phase
Intervention
Dasatinib in combination with imatinib
Why stopped
Insufficient Enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-02-17